Serum Calprotectin in Surgical Septic Patients

To early evaluate the serum levels of calprotectin in patients suffering from intra-abdominal sepsis requiring a surgical treatment. The research project aims to investigate the role of serum calprotectin in the diagnosis of sepsis and to establish whether its level significantly correlates with different degree of disease severity and with short and long-term outcomes. If these associations were confirmed, serum calprotectin would represent an easily and rapidly detectable biomarker able to predict the severity of sepsis.

NCT Number	NCT06614088
Lead Sponsor	Azienda Ospedaliero, Universitaria Pisana
Conditions	Infection, Intraabdominal, Sepsis Abdominal, Biomarker
Enrollment	150 participants
Start Date	2021-11-01
Primary Completion	2024-11-01 (estimated)
Study Completion	2025-01-01 (estimated)
Updated on ClinicalTrials.gov	2024-09-26